Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively.

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...

For decades, cancer screening has relied on imaging, bloodwork, and invasive testing. Now, one biotech company is taking a different approach. They’re combining dogs, breath samples, and AI to help ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Non-small cell lung cancer is ...

Lung cancer remains the leading cause of cancer-related mortality worldwide despite advances in early detection and treatment. Furthermore, its epidemiology has undergone a profound transformation, ...

Abstract: The issue of lung cancer diagnosis at early and correct stage is needed to enhance survival of patients and lower per capita mortality across the globe. Initially screening is commonly ...

A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought. Originally designed to ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Please provide your email address to receive an email when new articles are posted on . Less than half of older adults with metastatic lung cancer received systemic treatment. Findings underscore the ...

A new artificial intelligence tool called Sybil is helping doctors predict lung cancer risk years before it appears on scans, potentially closing gaps in current screening guidelines. Standard lung ...